Dataset Information

3D magnetization transfer (MT) for the visualization of cardiac free-running Purkinje fibers: an ex vivo proof of concept.

ABSTRACT:

Objectives

We investigate the possibility to exploit high-field MRI to acquire 3D images of Purkinje network which plays a crucial role in cardiac function. Since Purkinje fibers (PF) have a distinct cellular structure and are surrounded by connective tissue, we investigated conventional contrast mechanisms along with the magnetization transfer (MT) imaging technique to improve image contrast between ventricular structures of differing macromolecular content.

Methods

Three fixed porcine ventricular samples were used with free-running PFs on the endocardium. T1, T2*, T2, and M0 were evaluated on 2D slices for each sample at 9.4 T. MT parameters were optimized using hard pulses with different amplitudes, offset frequencies and durations. The cardiac structure was assessed through 2D and 3D T1w images with isotropic resolutions of 150 µm. Histology, immunofluorescence, and qPCR were performed to analyze collagen contents of cardiac tissue and PF.

Results

An MT preparation module of 350 ms duration inserted into the sequence with a B1 = 10 µT and frequency offset = 3000 Hz showed the best contrast, approximately 0.4 between PFs and myocardium. Magnetization transfer ratio (MTR) appeared higher in the cardiac tissue (MTR = 44.7 ± 3.5%) than in the PFs (MTR = 25.2 ± 6.3%).

Discussion

MT significantly improves contrast between PFs and ventricular myocardium and appears promising for imaging the 3D architecture of the Purkinje network.

SUBMITTER: Magat J

PROVIDER: S-EPMC8338918 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Dynamical systems theory suggests that studying the complexity of biological signals could lead to a single gait metric that reliably predicts risk of running-related injury (RRI). The purposes of this pilot study were to examine center of mass (COM) acceleration complexity at baseline, prior to RRI, and the change between timepoints between collegiate runners who developed RRI during a competitive season and those who remained uninjured, and to determine if complexity at these timepoints was associated with increased odds of RRI. Twenty-two collegiate runners from the same cross-country team wore a waist-mounted triaxial accelerometer (100 Hz) during easy-intensity runs throughout the competitive season. RRIs requiring medical attention were reported via an online survey. Control entropy was used to estimate the complexity of the resultant COM acceleration recorded during each run. Associations between complexity and RRI were assessed using a frequency-matching strategy where uninjured participants were paired with injured participants using complexity from the most time-proximal run prior to RRI. Seven runners sustained an RRI. No significant differences were observed between injured and uninjured groups for baseline complexity (p = 0.364, d = 0.405), pre-injury complexity (p = 0.258, d = 0.581), or change from baseline to pre-injury (p = 0.101, d = 0.963). There were no statistically significant associations found between complexity and RRI risk. Although no significant associations were found, the median effect from the models indicated that an increase in baseline complexity, pre-injury complexity, and change in complexity from baseline each corresponded to an increased odds of sustaining an RRI [baseline: odds ratio (OR) = 1.560, 95% CI = 0.587-4.143, p = 0.372; pre-injury: OR = 1.926, 95% CI: 0.689-5.382, p = 0.211; change from baseline: OR = 1.119; 95% CI: 0.839-1.491, p = 0.445). Despite non-significance and wide confidence intervals that included both positive and negative associations, the point estimates for >98% of the 10,000 frequency-case-control-matched model fits indicated that matching strategy did not influence the directionality of the association estimates between complexity and RRI risk (i.e., odds ratio >1.0). This pilot study demonstrates initial feasibility that additional research may support COM acceleration complexity as a useful single-metric monitoring system for RRI risk during real-world training. Follow-up work should assess longitudinal associations between gait complexity and running-related injury in larger cohorts.

Project description:BACKGROUND: Magnetic resonance imaging (MRI) plays an important role in tumor detection/diagnosis. The use of exogenous contrast agents (CAs) helps to improve the discrimination between lesion and neighbouring tissue, but most of the currently available CAs are non-specific. Assessing the performance of new, selective CAs requires exhaustive assays and large amounts of material. Accordingly, in a preliminary screening of new CAs, it is important to choose candidate compounds with good potential for in vivo efficiency. This screening method should reproduce as close as possible the in vivo environment. In this sense, a fast and reliable method to select the best candidate CAs for in vivo studies would minimize time and investment cost, and would benefit the development of better CAs. RESULTS: The post-mortem ex vivo relative contrast enhancement (RCE) was evaluated as a method to screen different types of CAs, including paramagnetic and superparamagnetic agents. In detail, sugar/gadolinium-loaded gold nanoparticles (Gd-GNPs) and iron nanoparticles (SPIONs) were tested. Our results indicate that the post-mortem ex vivo RCE of evaluated CAs, did not correlate well with their respective in vitro relaxivities. The results obtained with different Gd-GNPs suggest that the linker length of the sugar conjugate could modulate the interactions with cellular receptors and therefore the relaxivity value. A paramagnetic CA (GNP (E_2)), which performed best among a series of Gd-GNPs, was evaluated both ex vivo and in vivo. The ex vivo RCE was slightly worst than gadoterate meglumine (201.9?±?9.3% versus 237?±?14%, respectively), while the in vivo RCE, measured at the time-to-maximum enhancement for both compounds, pointed to GNP E_2 being a better CA in vivo than gadoterate meglumine. This is suggested to be related to the nanoparticule characteristics of the evaluated GNP. CONCLUSION: We have developed a simple, cost-effective relatively high-throughput method for selecting CAs for in vivo experiments. This method requires approximately 800 times less quantity of material than the amount used for in vivo administrations.